{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:18:30Z","timestamp":1791083910828,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T00:00:00Z","timestamp":1513123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Interdiscip Sci Comput Life Sci"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12539-017-0244-5","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T00:06:59Z","timestamp":1513123619000},"page":"153-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Structural Probing, Screening and Structure-Based Drug Repositioning Insights into the Identification of Potential Cox-2 Inhibitors from Selective Coxibs"],"prefix":"10.1007","volume":"11","author":[{"given":"Uma Devi","family":"Bommu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kranthi Kumar","family":"Konidala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishika","family":"Pamanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneetha","family":"Yeguvapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,13]]},"reference":[{"issue":"5","key":"244_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","volume":"83","author":"JR Molina","year":"2008","unstructured":"Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83(5):584\u2013594. \n                    https:\/\/doi.org\/10.4065\/83.5.584","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"244_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2217\/pme.14.19","volume":"11","author":"RA Okimoto","year":"2014","unstructured":"Okimoto RA, Bivona TG (2014) Recent advances in personalized lung cancer medicine. Per Med 11(3):309\u2013321","journal-title":"Per Med"},{"key":"244_CR3","doi-asserted-by":"publisher","first-page":"S479","DOI":"10.3978\/j.issn.2072-1439","volume":"5","author":"WA Cooper","year":"2013","unstructured":"Cooper WA, Lam DC, O\u2019Toole SA, Minna JD (2013) Molecular biology of lung cancer. J Thorac Dis 5:S479\u2013S490. \n                    https:\/\/doi.org\/10.3978\/j.issn.2072-1439","journal-title":"J Thorac Dis"},{"issue":"2","key":"244_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/sj.bjc.6603226","volume":"95","author":"C Mascaux","year":"2006","unstructured":"Mascaux C, Martin B, Paesmans M, Berghmans T, Dusart M, Haller A, Lothaire P, Meert AP, Lafitte JJ, Sculier JP (2006) Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results. Br J Cancer 95(2):139\u2013145","journal-title":"Br J Cancer"},{"key":"244_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","volume":"38","author":"JR Vane","year":"1998","unstructured":"Vane JR, Bakhle YS, Botting RM (1998) Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38:97\u2013120. \n                    https:\/\/doi.org\/10.1146\/annurev.pharmtox.38.1.97","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"27","key":"244_CR6","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.2174\/1381612033454054","volume":"9","author":"J Claria","year":"2003","unstructured":"Claria J (2003) Cyclooxygenase-2 biology. Curr Pharm Des 9(27):2177\u20132190","journal-title":"Curr Pharm Des"},{"issue":"6","key":"244_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0959-440X(01)00277-9","volume":"11","author":"RG Kurumbail","year":"2001","unstructured":"Kurumbail RG, Kiefer JR, Marnett LJ (2001) Cyclooxygenase enzymes: catalysis and inhibition. Curr Opin Struct Biol 11(6):752\u2013760","journal-title":"Curr Opin Struct Biol"},{"key":"244_CR8","first-page":"8","volume":"3","author":"PE Lipsky","year":"1999","unstructured":"Lipsky PE (1999) Role of cyclooxygenase-1 and -2 in health and disease. Am J Orthop 3:8\u201312","journal-title":"Am J Orthop"},{"issue":"12","key":"244_CR9","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1172\/JCI13271","volume":"107","author":"WL Smith","year":"2001","unstructured":"Smith WL, Langenbach R (2001) Why there are two cyclooxygenase isozymes. J Clin Invest 107(12):1491\u20131495. \n                    https:\/\/doi.org\/10.1172\/JCI13271","journal-title":"J Clin Invest"},{"key":"244_CR10","first-page":"15","volume":"49","author":"LJ Crofford","year":"1997","unstructured":"Crofford LJ (1997) COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol Suppl 49:15\u201319","journal-title":"J Rheumatol Suppl"},{"issue":"5","key":"244_CR11","first-page":"2006","volume":"6","author":"T Hida","year":"2000","unstructured":"Hida T, Kozaki K, Muramatsu H, Masuda A, Shimizu S, Mitsudomi T, Sugiura T, Ogawa M, Takahashi T (2000) Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res 6(5):2006\u20132011","journal-title":"Clin Cancer Res"},{"key":"244_CR12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00018-002-8468-9","volume":"59","author":"D Nie","year":"2002","unstructured":"Nie D, Honn KV (2002) Cyclooxygenase, lipoxygenase and tumor angiogenesis. Cell Mol Life Sci 59:799\u2013807","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"244_CR13","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/S0003-4975(03)00334-5","volume":"76","author":"JE Castelao","year":"2003","unstructured":"Castelao JE, Bart RD, DiPerna CA, Sievers EM, Bremner RM (2003) Lung cancer and cyclooxygenase-2. Ann Thorac Surg 76(4):1327\u20131335","journal-title":"Ann Thorac Surg"},{"issue":"18","key":"244_CR14","first-page":"4510","volume":"59","author":"HM Schuller","year":"1999","unstructured":"Schuller HM, Tithof PK, Williams M, Plummer H (1999) The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res 59(18):4510\u20134515","journal-title":"Cancer Res"},{"issue":"3","key":"244_CR15","first-page":"445","volume":"19","author":"HM Schuller","year":"2001","unstructured":"Schuller HM, Plummer HK, Bochsler PN, Dudric P, Bell JL, Harris RE (2001) Co-expression of beta-adrenergic receptors and cyclooxygenase-2 in pulmonary adenocarcinoma. Int J Oncol 19(3):445\u2013449","journal-title":"Int J Oncol"},{"issue":"5","key":"244_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.7150\/ijbs.3.328","volume":"3","author":"RE Harris","year":"2007","unstructured":"Harris RE, Beebe-Donk J, Alshafie GA (2007) Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study. Int J Biol Sci 3(5):328\u2013334","journal-title":"Int J Biol Sci"},{"issue":"2","key":"244_CR17","doi-asserted-by":"publisher","first-page":"81s","DOI":"10.18433\/J3T886","volume":"11","author":"P Rao","year":"2008","unstructured":"Rao P, Knaus EE (2008) Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci 11(2):81s\u2013110s","journal-title":"J Pharm Pharm Sci"},{"key":"244_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/00001648-199403000-00003","volume":"5","author":"DM Schreinemachers","year":"1994","unstructured":"Schreinemachers DM, Everson RB (1994) Aspirin use and lung, colon and breast cancer incidence in a prospective study. Epidemiology 5:138\u2013146","journal-title":"Epidemiology"},{"issue":"4","key":"244_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","volume":"94","author":"MJ Thun","year":"2002","unstructured":"Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94(4):252\u2013266","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"244_CR20","first-page":"655","volume":"10","author":"A Zarghi","year":"2011","unstructured":"Zarghi A, Arfaei S (2011) Selective COX-2 Inhibitors: a review of their structure-activity relationships. Iran J Pharm Res 10(4):655\u2013683","journal-title":"Iran J Pharm Res"},{"key":"244_CR21","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa050493","volume":"352","author":"RS Bresalier","year":"2005","unstructured":"Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA, Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092\u20131102","journal-title":"N Engl J Med"},{"key":"244_CR22","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1056\/NEJMoa050330","volume":"352","author":"NA Nussmeier","year":"2005","unstructured":"Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM (2005) Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 352:1081\u20131091","journal-title":"N Engl J Med"},{"key":"244_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/00365528909091168","volume":"163","author":"KE Giercksky","year":"1989","unstructured":"Giercksky KE, Huseby G, Rugstad HE (1989) Epidemiology of NSAID-related gastrointestinal side effects. Scand J Gastroenterol Suppl 163:3\u20138","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"7489","key":"244_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/bmj.330.7489.440","volume":"330","author":"J Lenzer","year":"2005","unstructured":"Lenzer J (2005) FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke. BMJ 330(7489):440","journal-title":"BMJ"},{"key":"244_CR25","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1185\/030079907X210561","volume":"8","author":"SX Sun","year":"2007","unstructured":"Sun SX, Lee KY, Bertram CT, Goldstein JL (2007) Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization. Curr Med Res Opin 8:1859\u20131866","journal-title":"Curr Med Res Opin"},{"key":"244_CR26","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0959-440X(97)80080-2","volume":"5","author":"C Ostermeier","year":"1997","unstructured":"Ostermeier C, Michel H (1997) Crystallization of membrane proteins. Curr Opin Struct Biol 5:697\u2013701","journal-title":"Curr Opin Struct Biol"},{"issue":"8","key":"244_CR27","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1021\/acs.biochem.5b01378","volume":"55","author":"MJ Lucido","year":"2016","unstructured":"Lucido MJ, Orlando BJ, Vecchio AJ, Malkowski MG (2016) Crystal structure of aspirin-acetylated human cyclooxygenase-2: insight into the formation of products with reversed stereochemistry. Biochemistry 55(8):1226\u20131238","journal-title":"Biochemistry"},{"issue":"29","key":"244_CR28","doi-asserted-by":"publisher","first-page":"15069","DOI":"10.1074\/jbc.M116.725713","volume":"291","author":"BJ Orlando","year":"2016","unstructured":"Orlando BJ, Malkowski MG (2016) Substrate-selective inhibition of cyclooxygenase-2 by fenamic acid derivatives is dependent on peroxide tone. J Biol Chem 291(29):15069\u201315081","journal-title":"J Biol Chem"},{"issue":"3","key":"244_CR29","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A Sali","year":"1993","unstructured":"Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234(3):779\u2013815","journal-title":"J Mol Biol"},{"key":"244_CR30","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/elps.1150181505","volume":"15","author":"N Guex","year":"1997","unstructured":"Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 15:2714\u20132723","journal-title":"Electrophoresis"},{"key":"244_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283\u2013291","journal-title":"J Appl Crystallogr"},{"issue":"6364","key":"244_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/356083a0","volume":"356","author":"R Luthy","year":"1992","unstructured":"Luthy R, Bowie JU, Eisenberg D (1992) Assessment of protein models with three-dimensional profiles. Nature 356(6364):83\u201385","journal-title":"Nature"},{"key":"244_CR33","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"9","author":"C Colovos","year":"1993","unstructured":"Colovos C, Yeates TO (1993) Verification of protein structures: patterns of non-bonded atomic interactions. Protein Sci 9:1511\u20131519","journal-title":"Protein Sci"},{"key":"244_CR34","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35:W407\u2013W410","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"244_CR35","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"JJ Irwin","year":"2012","unstructured":"Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: a free tool to discover chemistry for biology. J Chem Inf Model 52(7):1757\u20131768. \n                    https:\/\/doi.org\/10.1021\/ci3001277","journal-title":"J Chem Inf Model"},{"issue":"11","key":"244_CR36","doi-asserted-by":"publisher","first-page":"e109185","DOI":"10.1371\/journal.pone.0109185","volume":"9","author":"KN Chitrala","year":"2014","unstructured":"Chitrala KN, Yeguvapalli S (2014) Computational Prediction and analysis of breast cancer targets for 6-Methyl-1, 3, 8-trichlorodibenzofuran. PLoS One 9(11):e109185. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0109185","journal-title":"PLoS One"},{"issue":"11","key":"244_CR37","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/jcc.21816","volume":"32","author":"V Zoete","year":"2011","unstructured":"Zoete V, Cuendet MA, Grosdidier A, Michielin O (2011) SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 32(11):2359\u20132368","journal-title":"J Comput Chem"},{"key":"244_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","volume":"1263","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx. Methods Mol Biol 1263:243\u2013250. \n                    https:\/\/doi.org\/10.1007\/978-1-4939-2269-7_19","journal-title":"Methods Mol Biol"},{"key":"244_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nbt1284","volume":"2","author":"MJ Keiser","year":"2007","unstructured":"Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK (2007) Relating protein pharmacology by ligand chemistry. Nat Biotechnol 2:197\u2013206","journal-title":"Nat Biotechnol"},{"issue":"4","key":"244_CR40","first-page":"251","volume":"10","author":"MT Nelson","year":"1996","unstructured":"Nelson MT, Humphrey W, Gursoy A et al (1996) NAMD: a parallel, object-oriented molecular dynamics program. Int J Supercomput 10(4):251\u2013268","journal-title":"Int J Supercomput"},{"issue":"1","key":"244_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph\u00a014(1):33\u201338","journal-title":"J Mol Graph"},{"key":"244_CR42","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1021\/ct3003089","volume":"8","author":"DE Tanner","year":"2012","unstructured":"Tanner DE, Phillips JC, Schulten K (2012) GPU\/CPU algorithm for generalized Born\/solvent-accessible surface area implicit solvent calculations. J Chem Theor Comp 8:2521\u20132530","journal-title":"J Chem Theor Comp"},{"key":"244_CR43","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/protein\/7.3.385","volume":"7","author":"J Aqvist","year":"1994","unstructured":"Aqvist J, Medina C (1994) A new method for predicting binding affinity in computer-aided drug design. Protein Eng 7:385\u2013391","journal-title":"Protein Eng"},{"key":"244_CR44","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1063\/1.470648","volume":"103","author":"SE Feller","year":"1995","unstructured":"Feller SE, Zhang Y, Pastor RW, Brooks BR (1995) Constant pressure molecular dynamics simulation: the Langevin piston method. J Chem Phys 103:4613\u20134621","journal-title":"J Chem Phys"},{"issue":"12","key":"244_CR45","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1021\/ci500467k","volume":"54","author":"A Daina","year":"2014","unstructured":"Daina A, Michielin O, Zoete V (2014) iLOGP: a simple, robust, and efficient description of n-octanol\/water partition coefficient for drug design using the GB\/SA approach. J Chem Inf Model 54(12):3284\u20133301","journal-title":"J Chem Inf Model"},{"issue":"1","key":"244_CR46","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1124\/pr.112.007336","volume":"66","author":"G Sliwoski","year":"2013","unstructured":"Sliwoski G, Kothiwale S, Meiler J Jr, Lowe EW (2013) Computational methods in drug discovery. Pharmacol Rev 66(1):334\u2013395","journal-title":"Pharmacol Rev"},{"issue":"24","key":"244_CR47","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1093\/bioinformatics\/btt560","volume":"29","author":"GQ Dong","year":"2013","unstructured":"Dong GQ, Fan H, Schneidman-Duhovny D, Webb B, Sali A (2013) Optimized atomic statistical potentials: assessment of protein interfaces and loops. Bioinformatics 29(24):3158\u20133166","journal-title":"Bioinformatics"},{"key":"244_CR48","first-page":"660","volume":"5","author":"H Yokouchi","year":"2015","unstructured":"Yokouchi H, Kanazawa K (2015) Revisiting the role of COX-2 inhibitor for non-small cell lung cancer. Transl Lung Cancer Res 5:660\u2013664","journal-title":"Transl Lung Cancer Res"},{"issue":"9","key":"244_CR49","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1021\/jm960803q","volume":"40","author":"TD Penning","year":"1997","unstructured":"Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM, Rogers RS, Rogier DJ, Yu SS, Anderson GD, Burton EG, Cogburn JN, Gregory SA, Koboldt CM, Perkins WE, Seibert K, Veenhuizen AW, Zhang YY, Isakson PC (1997) Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, celecoxib). J Med Chem 40(9):1347\u20131365","journal-title":"J Med Chem"},{"key":"244_CR50","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-1-61779-588-6_10","volume":"857","author":"I Kufareva","year":"2012","unstructured":"Kufareva I, Abagyan R (2012) Methods of protein structure comparison. Methods Mol Biol 857:231\u2013257","journal-title":"Methods Mol Biol"}],"container-title":["Interdisciplinary Sciences: Computational Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12539-017-0244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12539-017-0244-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12539-017-0244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T11:19:47Z","timestamp":1567855187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12539-017-0244-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,13]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["244"],"URL":"https:\/\/doi.org\/10.1007\/s12539-017-0244-5","relation":{},"ISSN":["1913-2751","1867-1462"],"issn-type":[{"value":"1913-2751","type":"print"},{"value":"1867-1462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,13]]},"assertion":[{"value":"20 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors announce that they have no conflict of interest about this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}